Enter assignee name

Forward Citations = 68

Loading Chart...

7 inventors (with patents filed for the assignee):

Mary George Johnson (5 out of 11 patents)

Jack B Jiang (5 out of 5 patents)

Jeffrey B Nichols (2 out of 2 patents)

4. Robert M Bell (1 out of 4 patents)

5. Robert J Fogelsong (1 out of 1 patent)

6. Jean M Defauw (1 out of 1 patent)

7. G Erik Jagdmann, Jr (1 out of 2 patents)

8 patents: Sort by Forward Citations

1. 5432198 - Vicinal-substituted carbocyclic compounds as therapeutic agents (1995-07-11),

2. 5360818 - 1,3-dioxane derivatives having protein kinase C inhibitory activity (1994-11-01),

3. 5344841 - Bis-(hydroxylakylamino)-anthraquinone inhibitors of protein kinase C (1994-09-06),

4. 5292737 - N,N'-bis(sulfonamido)-2-amino-4-iminonaphthalen-1-ones and (1994-03-08),

5. 5270310 - N-aminoalkyl amide inhibitors of protein kinase C (1993-12-14),

6. 5216014 - Furo-coumarinsulfonamides as protein kinase C inhibitors (1993-06-01),

7. 5204370 - Bis-(hydroxyalkylamino)-anthraquinone inhibitors of protein kinase C (1993-04-20),

8. 5141957 - 1,4-bis-(amino-hydroxyalkylamino)-anthraquinones for inhibiting protein (1992-08-25),

Sphinx Pharmaceuticals Corporation is a leading pharmaceutical company specializing in the research and development of innovative drugs. With a focus on improving patient outcomes, Sphinx Pharmaceuticals is committed to discovering new treatments for various diseases and medical conditions. The company's state-of-the-art facilities and experienced team of researchers have led to numerous breakthroughs in the field of medicine. Sphinx Pharmaceuticals strives to make a positive impact on global healthcare through their cutting-edge products and services.

This text is generated by artificial intelligence and may not be accurate.